迪视医疗完成数千万A2轮融资，持续深耕超显微手术机器人赛道

Core Viewpoint - The article discusses the advancements and market potential of Hangzhou Dishi Medical Biotechnology Co., Ltd. in the field of surgical robotics, particularly focusing on its innovative micro-surgical robots that address unmet clinical needs and enhance surgical precision [2][5]. Group 1: Company Overview - Dishi Medical has completed a multi-million A2 round financing led by Dacheng Capital, with continued investment from Panlin Capital, aimed at accelerating the market adoption of its ultra-micro surgical robots [2]. - The company specializes in robotic micro-manipulation technology, focusing on ultra-micro surgical robots that can overcome the limitations of human hands, addressing significant clinical demands in the surgical field [2][5]. Group 2: Product Development and Innovation - Dishi Medical's ultra-micro technology allows for more stable and precise operations in complex retinal procedures, significantly reducing surgical damage and enabling the delivery of innovative drugs [5]. - The company has developed a range of products, including eye surgery robots, surgical simulation systems, instrument robots, micro-injection pumps, and micro-injection needles, continuously advancing its core technology platform [8]. Group 3: Market Potential and Impact - In China, there are over 40 million patients with retinal diseases, and cataract surgeries are projected to exceed 5 million by 2025, indicating a substantial market opportunity for Dishi Medical's products [5]. - The eye surgery robot has entered the National Medical Products Administration (NMPA) special review "green channel," making it the first eye surgery robot in China to achieve this status, which is expected to enhance its market presence [5][8]. Group 4: Clinical Achievements - Dishi Medical has successfully completed the first international robot-assisted deep cervical lymphatic-venous anastomosis and the first domestic superficial limb lymphatic-venous anastomosis, demonstrating superior stability and safety in complex surgical procedures [6].